SCHEMBL2303130

SCHEMBL2303130

NCCCC[C@H](NO)C(=O)OC1(C2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PYGB P11216 2/20 0.33
▸ IGF2R P11717 1/20 0.33
▸ LGALS3 P17931 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269327 0.78 PYGB (0.34) PYGB
SCHEMBL6753925 0.76 PYGB (0.33) PYGBIGF2RLGALS3
SCHEMBL699573 0.75 IGF2R (0.40) IGF2RLGALS3
SCHEMBL28251135 0.74 PYGB (0.37) PYGB
SCHEMBL27576968 0.74 PYGB (0.37) PYGB
SCHEMBL28118024 0.74 PYGB (0.37) PYGB
SCHEMBL6743838 0.71 LGALS3 (0.31) IGF2RLGALS3
SCHEMBL2723573 0.71 PYGB (0.43) PYGB
SCHEMBL28448523 0.70 CA12 (0.44) PYGB
SCHEMBL28444663 0.70 CA12 (0.44) PYGB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021034771-A1 SURROGATE OF VO2 MAX TEST THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-02-25 — — WO claimed
WO-2017189528-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME Ecolab USA, Inc. (US) 2017-11-02 — — WO claimed
US-20170306504-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME CHAMPIONX LLC 2017-10-26 — — US claimed
EP-2349326-A2 A NEW PHARMACEUTICAL PRODUCT Oulun Yliopisto (FI) 2011-08-03 — — EP claimed
US-20100124548-A1 Pharmaceutical product UNIVERSITY OF OULU (FI) 2010-05-20 — — US claimed
WO-2010049590-A2 A NEW PHARMACEUTICAL PRODUCT OULUN YLIOPISTO (FI) 2010-05-06 — — WO claimed
EP-2115463-A2 BIOMARKERS OF IONIZING RADIATION RESPONSE Wisconsin Alumni Research Foundation (US) 2009-11-11 — — EP claimed
WO-2008097491-A2 BIOMARKERS OF IONIZING RADIATION RESPONSE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-08-14 — — WO claimed
US-20080187952-A1 Biomarkers of Ionizing Radiation Response WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-08-07 — — US claimed
WO-2022083720-A1 GLP1-GCGR ANTIBODY FUSION PROTEIN VARIANT AND COMPOSITION COMPRISING SAME 江苏恒瑞医药股份有限公司 2022-04-28 — — WO disclosed
WO-2021034771-A1 SURROGATE OF VO2 MAX TEST THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-02-25 — — WO disclosed
US-20190391092-A1 METABOLIC PROFILING WITH MAGNETIC RESONANCE MASS SPECTROMETRY (MRMS) Oregon Institute of Science and Medicine 2019-12-26 — — US disclosed
WO-2017189528-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME Ecolab USA, Inc. (US) 2017-11-02 — — WO disclosed
US-20170306504-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME CHAMPIONX LLC 2017-10-26 — — US disclosed
EP-0675903-B1 BONE RESORPTION ASSAY BAYLINK DAVID J (US) 2004-09-29 — — EP disclosed
US-5965136-A RECOMBINANT PEPTIDE HAVING AN EPITOPE OF GIVEN AMINO ACID SEQUENCE WHICH IMMUNOLOGICALLY COMPETES WITH C-TELOPEPTIDE OF TYPE I COLLAGEN; ACCURATE DIAGNOSIS OF OSTEOPOROSIS; LACKS HYDROXYLYSLPYRIDINOLINE AND LYSYLPYRIDINOLINE CROSSLINKS BAYLINK DAVID J (US) 1999-10-12 — — US disclosed
US-5753450-A DETERMINING LEVELS OF C-TELOPEPTIDE OF HUMAN TYPE I COLLAGEN,USING LEVELS AS MARKERS OF COLLAGEN DEGRADATION BAYLINK DAVID J (US) 1998-05-19 — — US disclosed
EP-0675903-A4 BONE RESORPTION ASSAY. BAYLINK DAVID J (US) 1997-11-12 — — EP disclosed
EP-0675903-A1 BONE RESORPTION ASSAY Baylink, David J (US) 1995-10-11 — — EP disclosed
WO-1994014844-A1 BONE RESORPTION ASSAY BAYLINK DAVID J (US) 1994-07-07 — — WO disclosed
Send feedback